ALFA Filings
Every announcement, straight from the exchange
Every Krsnaa Diagnostics earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Krsnaa reported 22% revenue growth but suffered margin compression due to heavy front-ended costs for the Rajasthan project. Management pivots to 'long-term value' to deflect from current EBITDA and PAT dips.
Krsnaa Diagnostics reported 22% revenue growth in Q1 FY27, driven by expanding retail business and PPP project scaling, despite margin pressure from Rajasthan operationalization.
Krsnaa Diagnostics reports 8% revenue growth and crossing ₹100cr PAT milestone in FY26, driven by PPP scaling and a sixfold growth in retail diagnostics.
Krsnaa Diagnostics reported FY26 revenue of ₹7,728 Mn (up 8% YoY) and PAT of ₹1,013 Mn (up 31% YoY). Strategy focuses on PPP model and aggressive retail expansion.